<?xml version="1.0" encoding="UTF-8"?>
<p>Concentrations of various factors (BDNF, NGF, CRP, C3, C4, ANGP2, and VEGF) in the CSF were quantified by multiplex fluorescent bead-based immunoassays (Luminex Corporation, Austin, TX, USA) in samples collected on the day of the cell injection and one month later. Additionally, we also assessed levels of BDNF and NGF in patients’ plasma on the day of injection, three and seven days after treatment, and three and six months after treatment. The procedure was performed according to the manufacturer’s protocol, as previously described [
 <xref rid="B76-ijms-19-01312" ref-type="bibr">76</xref>].
</p>
